The effects of activated charcoal on digoxin and digitoxin clearance
The effect of multiple oral doses of activated charcoal on digitalis glycoside kinetics was studied to determine whether an activated charcoal regimen might have utility in treating patients with digitalis toxicity. Normal subjects were given intravenous infusions of digoxin 0.75 mg/70 kg or digitox...
Saved in:
Published in | Drug intelligence & clinical pharmacy Vol. 19; no. 12; p. 937 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.12.1985
|
Subjects | |
Online Access | Get more information |
ISSN | 0012-6578 |
DOI | 10.1177/106002808501901216 |
Cover
Abstract | The effect of multiple oral doses of activated charcoal on digitalis glycoside kinetics was studied to determine whether an activated charcoal regimen might have utility in treating patients with digitalis toxicity. Normal subjects were given intravenous infusions of digoxin 0.75 mg/70 kg or digitoxin 1 mg/70 kg iv followed by either water alone or water with activated charcoal in divided doses in a randomized crossover design. A subject with chronic renal failure was also given digoxin 0.5 mg/70 kg iv followed by water alone or water with activated charcoal. In six normal subjects, treatment with activated charcoal did not increase digoxin clearance (Cl) significantly (16.79 +/- 1.70 vs. 22.68 +/- 3.51 L/h). However, digitoxin Cl did increase significantly, from 0.24 +/- 0.01 to 0.47 +/- 0.04 L/h. In the renal failure subject, digoxin Cl increased from 3.6 L/h to 10.1 L/h. We conclude that the activated charcoal regimen is probably useful in patients with digitoxin toxicity. Although similar benefit is limited in patients with normal renal function who develop digoxin toxicity, it is possible that activated charcoal will be useful in patients with prolonged digoxin elimination due to renal dysfunction. |
---|---|
AbstractList | The effect of multiple oral doses of activated charcoal on digitalis glycoside kinetics was studied to determine whether an activated charcoal regimen might have utility in treating patients with digitalis toxicity. Normal subjects were given intravenous infusions of digoxin 0.75 mg/70 kg or digitoxin 1 mg/70 kg iv followed by either water alone or water with activated charcoal in divided doses in a randomized crossover design. A subject with chronic renal failure was also given digoxin 0.5 mg/70 kg iv followed by water alone or water with activated charcoal. In six normal subjects, treatment with activated charcoal did not increase digoxin clearance (Cl) significantly (16.79 +/- 1.70 vs. 22.68 +/- 3.51 L/h). However, digitoxin Cl did increase significantly, from 0.24 +/- 0.01 to 0.47 +/- 0.04 L/h. In the renal failure subject, digoxin Cl increased from 3.6 L/h to 10.1 L/h. We conclude that the activated charcoal regimen is probably useful in patients with digitoxin toxicity. Although similar benefit is limited in patients with normal renal function who develop digoxin toxicity, it is possible that activated charcoal will be useful in patients with prolonged digoxin elimination due to renal dysfunction. |
Author | Park, G D Spector, R Roberts, P Goldberg, M J Feldman, R D Quee, C K Johnson, G F |
Author_xml | – sequence: 1 givenname: G D surname: Park fullname: Park, G D – sequence: 2 givenname: M J surname: Goldberg fullname: Goldberg, M J – sequence: 3 givenname: R surname: Spector fullname: Spector, R – sequence: 4 givenname: G F surname: Johnson fullname: Johnson, G F – sequence: 5 givenname: R D surname: Feldman fullname: Feldman, R D – sequence: 6 givenname: C K surname: Quee fullname: Quee, C K – sequence: 7 givenname: P surname: Roberts fullname: Roberts, P |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/4085353$$D View this record in MEDLINE/PubMed |
BookMark | eNotj8FKAzEURbOo1Lb6A4KQHxh9SSbJ61KqVqHgpq7Lm-TFjkwzZWYU_XtH7eqeC4cLdy4muc0sxJWCG6W8v1XgADQCWlBLUFq5iZjBCIWzHs_FvO_fAQwsnZuKaTl6xpqZuN_uWXJKHIZetklSGOpPGjjKsKcutNTINstYv7VfdZaU4y_Xw18LDVNHOfCFOEvU9Hx5yoV4fXzYrp6Kzcv6eXW3KYJxy6GIFSSLZCrLqsTkWJOyAVlb1BFT8FiZCpR36EeJokeMqDQmr5MpbdILcf2_e_yoDhx3x64-UPe9O73RPzc2TB0 |
CitedBy_id | crossref_primary_10_1053_ajkd_2000_8291 crossref_primary_10_1081_CLT_100102451 crossref_primary_10_2165_00129784_200606020_00002 crossref_primary_10_1177_0310057X9001800315 crossref_primary_10_3109_15563659409011043 crossref_primary_10_2165_00003088_200746110_00001 crossref_primary_10_2165_00042310_200723020_00007 crossref_primary_10_1111_j_1365_2710_1993_tb00564_x crossref_primary_10_1016_S1164_6756_05_80006_4 crossref_primary_10_1016_S0196_0644_89_80116_7 crossref_primary_10_1080_15563650_2021_1961144 crossref_primary_10_1111_j_1600_0773_1993_tb01644_x crossref_primary_10_1016_S0749_0704_18_30471_8 crossref_primary_10_5694_j_1326_5377_1990_tb124464_x crossref_primary_10_1016_S0196_0644_95_70295_4 crossref_primary_10_1111_j_1365_2125_2012_04449_x crossref_primary_10_1111_bcp_12814 crossref_primary_10_1016_0735_6757_91_90162_D crossref_primary_10_1097_FTD_0b013e31802bfd69 crossref_primary_10_1016_0735_6757_92_90210_O crossref_primary_10_1097_MAJ_0b013e318176b94d crossref_primary_10_1016_S0196_0644_05_81608_7 crossref_primary_10_1111_bcpt_13553 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1177/106002808501901216 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
ExternalDocumentID | 4085353 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, U.S. Gov't, P.H.S Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: NCRR NIH HHS grantid: RR00059 – fundername: NCRR NIH HHS grantid: RR 07035-16 |
GroupedDBID | .GJ 41~ 53G 5RE AACKU AAGGD AAJIQ AAJOX AANSI AAPEO AAQXH AARDL AAWTL AAXOT AAYTG AAZBJ ABDWY ABHKI ABJNI ABPGX ABQKF ABVVC ABYTW ACFMA ACFYK ACGBL ACGFS ACLHI ADEIA ADMPF ADNBR ADTBJ ADUKL AECVZ AEWDL AEXFG AFFNX AFKBI AIGRN AJABX AJEFB AJMMQ AJSCY ALMA_UNASSIGNED_HOLDINGS CBRKF CGR CORYS CQQTX CUTAK CUY CVF DC0 DD- DD0 DE- DE. DN0 ECM EIF F5P NPM Q1R ROL SAUOL SCNPE SFC ZGI |
ID | FETCH-LOGICAL-c369t-db0f58a3b5e148f6e2a15c8e2582d8fc78b3b017687a3bad788d8128f72f345f2 |
ISSN | 0012-6578 |
IngestDate | Wed Feb 19 02:35:49 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c369t-db0f58a3b5e148f6e2a15c8e2582d8fc78b3b017687a3bad788d8128f72f345f2 |
PMID | 4085353 |
ParticipantIDs | pubmed_primary_4085353 |
PublicationCentury | 1900 |
PublicationDate | 19851200 |
PublicationDateYYYYMMDD | 1985-12-01 |
PublicationDate_xml | – month: 12 year: 1985 text: 19851200 |
PublicationDecade | 1980 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Drug intelligence & clinical pharmacy |
PublicationTitleAlternate | Drug Intell Clin Pharm |
PublicationYear | 1985 |
SSID | ssj0030966 |
Score | 1.3862648 |
Snippet | The effect of multiple oral doses of activated charcoal on digitalis glycoside kinetics was studied to determine whether an activated charcoal regimen might... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 937 |
SubjectTerms | Adult Charcoal - therapeutic use Digitoxin - adverse effects Digitoxin - metabolism Digoxin - adverse effects Digoxin - metabolism Humans Kidney Failure, Chronic - metabolism Kidney Failure, Chronic - therapy Kinetics Male |
Title | The effects of activated charcoal on digoxin and digitoxin clearance |
URI | https://www.ncbi.nlm.nih.gov/pubmed/4085353 |
Volume | 19 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8QwFA4uCF7EFXdyEC9amabN0qM4LgjKHEbwJk2TiKDtoKOov96XJpOWcUG9lE4yhJl-X17fS973gtCO6aRaZSyPYq7TKNUdmFKa2RyxJBcmNx3FrHb44pKdXaXn1_S62cGv1SVDeVC8f6kr-Q-q0Aa4WpXsH5ANg0ID3AO-cAWE4fprjFsJGVaj8JJbF9JqqYrK-pnlnrq7rV7vXM4x3MMMtp8Ke1xEQNx7p93H59u6gEQo0mmJEcSTA1fmOizC93ye9WmTNnxa3atRxthFa8tp4DcHWgmK_mwuN8BJs_oQZ4K2Mjm8RYUGRt0xPMGiZm3mkJZ9zFyFl892u945hvC03uoV1CrcY-JUmC0gBw81krYqW-JqDP_YOVZJ2_dMoknOrQ2_tAs77qWdQCTH3Evb_Z2RvqquTDD-q2bRjB9rLBipnZL-PJrz0QQ-dNRYQBO6XES7PY_TPu436rqnfbyLe02h8rcl1IVu7PmDK4MDf_CIP7gqsecPBv7gwB8c-LOMrk6O-0dnkT9VIyoSlg0jJTuGijyRVEMobJgmeUwLoQkVRAlTcCETCXaaCQ5fyhUXQoEXKAwnJkmpIStoqqxKvYqwkVJIAjZAQVRKMhiAq9gQXlBuw-Z0Da24p3MzcKVTbvxjW_-uYwPNNizbRNMGZqreArdvKLdrwD4AKwtS8g |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effects+of+activated+charcoal+on+digoxin+and+digitoxin+clearance&rft.jtitle=Drug+intelligence+%26+clinical+pharmacy&rft.au=Park%2C+G+D&rft.au=Goldberg%2C+M+J&rft.au=Spector%2C+R&rft.au=Johnson%2C+G+F&rft.date=1985-12-01&rft.issn=0012-6578&rft.volume=19&rft.issue=12&rft.spage=937&rft_id=info:doi/10.1177%2F106002808501901216&rft_id=info%3Apmid%2F4085353&rft_id=info%3Apmid%2F4085353&rft.externalDocID=4085353 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-6578&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-6578&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-6578&client=summon |